These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16182784

  • 1. Role of immunosuppressive regimen on the incidence and characteristics of cytomegalovirus infection in heart transplantation: a single-center experience with preemptive therapy.
    De Santo LS, Romano G, Mastroianni C, Roberta C, Della Corte A, Amarelli C, Maiello C, Giannolo B, Marra C, Ragone E, Grimaldi M, Utili R, Scardone M, Cotrufo M.
    Transplant Proc; 2005; 37(6):2684-7. PubMed ID: 16182784
    [Abstract] [Full Text] [Related]

  • 2. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ, Malaise J, Moreno A, Crespo M, Fernández-Cruz L, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and limitations of preemptive therapy against cytomegalovirus infections in heart transplant patients.
    Casillo R, Grimaldi M, Ragone E, Maiello C, Marra C, De Santo L, Amarelli C, Romano G, Della Corte A, Portella G, Tripodi MF, Fortunato R, Cotrufo M, Utili R.
    Transplant Proc; 2004 Apr; 36(3):651-3. PubMed ID: 15110622
    [Abstract] [Full Text] [Related]

  • 5. CMV in kidney transplantation: a single center experience over 22 years.
    Nashan B, Lück R, Kliem V, Brunkhorst R, Schlitt HJ, Klempnauer J.
    Clin Transpl; 1999 Apr; ():181-8. PubMed ID: 11038636
    [Abstract] [Full Text] [Related]

  • 6. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
    Said T, Nampoory MR, Johny KV, Pacsa AS, Mini Abraham P, Nair MP, Abdel-Haleem M, Samhan M, Al-Mousawi M.
    Transplant Proc; 2004 Apr; 36(6):1847-9. PubMed ID: 15350495
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras.
    Boucher A, Lord H, Collette S, Morin M, Dandavino R.
    Transplant Proc; 2006 Dec; 38(10):3506-8. PubMed ID: 17175316
    [Abstract] [Full Text] [Related]

  • 8. Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation.
    Kobashigawa J, Ross H, Bara C, Delgado JF, Dengler T, Lehmkuhl HB, Wang SS, Dong G, Witte S, Junge G, Potena L.
    Transpl Infect Dis; 2013 Apr; 15(2):150-62. PubMed ID: 23013440
    [Abstract] [Full Text] [Related]

  • 9. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J, Morales-Buenrostro LE, Correa-Rotter R, Muñoz-Trejo T, Zúñiga-Varga J, Cuéllar-González JV, Mayorga-Madrigal H, Vanegas-Carrero R, Aranda F, Rodríguez-Romo R, Herrera-Garcia C, González-Michaca L, Sierra-Madero JG.
    Rev Invest Clin; 2008 Apr; 60(5):365-74. PubMed ID: 19227433
    [Abstract] [Full Text] [Related]

  • 10. [Cytomegalovirus infection after heart transplantation. Retrospective analysis of an antiviral CMV prevention].
    Antretter H, Höfer D, Klaus A, Larcher C, Margreiter J, Margreiter R.
    Dtsch Med Wochenschr; 2000 Apr 14; 125(15):445-51. PubMed ID: 10800441
    [Abstract] [Full Text] [Related]

  • 11. Clinical usefulness of human cytomegalovirus antigenemia assay after kidney transplantation.
    Kim CK, Song JH, Kim SM, Peck KR, Oh W, Huh W, Kim YG, Kim SJ, Joh JW, Lee NY, Park CG, Hwang ES, Cha CY, Oh HY.
    Transplantation; 2003 Jun 27; 75(12):2151-5. PubMed ID: 12829929
    [Abstract] [Full Text] [Related]

  • 12. Cytomegalovirus infection and disease following renal transplantation: preliminary report of incidence and potential risk factors.
    Taherimahmoudi M, Ahmadi H, Baradaran N, Montaser-Kouhsari L, Salem S, Mehrsai A, Kalantar E, Jahani Y, Pourmand G.
    Transplant Proc; 2009 Sep 27; 41(7):2841-4. PubMed ID: 19765452
    [Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus infections in cardiac transplant patients: an experience at a clinical hospital, university of Chile.
    Sepulveda L, Llancaqueo M, Zamorano J, Bermudez C, Cortes C.
    Transplant Proc; 2007 Apr 27; 39(3):622-4. PubMed ID: 17445560
    [Abstract] [Full Text] [Related]

  • 14. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
    Basic-Jukic N, Kes P, Bubic-Filipi LJ, Puretic Z, Brunetta B, Pasini J.
    Transplant Proc; 2005 Mar 27; 37(2):850-1. PubMed ID: 15848553
    [Abstract] [Full Text] [Related]

  • 15. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D, Rayes N, Tullius SG, Schmidt CA, Neumann UP, Radke C, Settmacher U, Müller AR, Steinmüller T, Neuhaus P.
    Liver Transpl; 2002 Dec 27; 8(12):1138-46. PubMed ID: 12474153
    [Abstract] [Full Text] [Related]

  • 16. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T, Jindra P, Hes O, Bouda M, Kormunda S, Treska V.
    Transplantation; 2009 Feb 15; 87(3):436-44. PubMed ID: 19202451
    [Abstract] [Full Text] [Related]

  • 17. 20-year follow-up results of a randomized controlled trial comparing antilymphocyte globulin induction to no induction in renal transplant patients.
    Cantarovich M, Durrbach A, Hiesse C, Ladouceur M, Benoit G, Charpentier B.
    Transplantation; 2008 Dec 27; 86(12):1732-7. PubMed ID: 19104413
    [Abstract] [Full Text] [Related]

  • 18. The effect of cytomegalovirus antigenemia titer on the efficacy of preemptive therapy for the prevention of cytomegalovirus disease after kidney transplantation.
    Jung GO, Kim SJ, Choi GS, Moon JI, Kim JM, Sin MJ, Kim EY, Kwon CH, Joh JW, Lee SK.
    Transplant Proc; 2010 Apr 27; 42(3):804-10. PubMed ID: 20430177
    [Abstract] [Full Text] [Related]

  • 19. Influence of cytomegalovirus disease on early and late renal graft function.
    Boratyńska M, Banasik M, Watorek E, Patrzałek D, Szyber P, Klinger M.
    Transplant Proc; 2006 Apr 27; 38(1):147-50. PubMed ID: 16504688
    [Abstract] [Full Text] [Related]

  • 20. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A, Daniel V, Dengler TJ, Schnabel PA, Hagl S, Sack FU.
    J Heart Lung Transplant; 2005 Jun 27; 24(6):708-13. PubMed ID: 15949731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.